HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have HIV-1.
- People who have suitable veins for research blood draws.
- People who have a confirmed positive HIV test result meeting current CDC standards, or — for those with a suspected very early HIV infection — a viral load above 2,000 copies/ml with a negative antibody test result.
- People who are willing and able to attend at least one follow-up visit within the next 4 months, before starting HIV treatment.
- People whose blood pressure is below 180/100 and whose pulse rate is between 50 and 100 beats per minute (or whose lower pulse rate is considered normal for them).
- People whose blood counts meet minimum levels: haemoglobin at least 9.0 g/dL, haematocrit at least 28%, and platelets at least 50,000.
- People who are willing and able to give informed consent, including consent for blood sample storage and genetic testing.
- People who have never taken antiretroviral (HIV) treatment, have not taken it in the last six months, or were previously enrolled in a related study with samples already stored.
- People who acquired HIV while taking medication to prevent HIV infection (pre-exposure prophylaxis) may also be eligible, provided their HIV diagnosis meets the required criteria.
- People enrolled in a related study in the past three months who complete a specific blood collection procedure within 4 weeks of starting HIV treatment may also be eligible.
- People with very limited recent HIV treatment use (no more than 4 weeks before the screening visit) may be eligible if the trial investigators determine that this use would not affect the scientific value of the study (confirm with trial site).
Who may not be able to join:
- People who are pregnant or breastfeeding.
- People who are currently misusing alcohol or other substances in a way that could affect their safety or ability to follow the study requirements.
- People who have a medical or other condition that, in the investigators' judgement, would make participation unsuitable (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Susan L Moir, Ph.D., National Institute of Allergy and Infectious Diseases (NIAID)
Phone: (301) 435-8003
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To further investigate differences in the immunologic function of various lymphocyte subsets in PWH who are treated early after transmission of HIV and during the chronic phase of the disease.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.